Megan Ruhland, Ph.D.
- Assistant Professor of Cell, Developmental and Cancer Biology, School of Medicine
- Assistant Professor of Dermatology, School of Medicine
Biography
Megan Ruhland, Ph.D., is an assistant professor in Cell, Developmental and Cancer Biology, with a secondary appointment in Dermatology, at OHSU School of Medicine. Her work studies the immune system's response to cancer with the goal of re-educating immune cells to fight disease. Specifically, Dr. Ruhland focuses on the ability of antigen-presenting immune cells to stimulate productive anti-tumor T cell responses. Beyond cancer, the Ruhland lab works to better understand how the immune system functions to maintain tissue homeostatsis and how dysfunction can ultimately contribute to disease.
Education and training
-
Degrees
- B.S., 2009, Creighton University
- Ph.D., 2015, Washington University in St. Louis
Memberships and associations:
- American Association for Cancer Research
- Society for Immunotherapy of Cancer
Areas of interest
- melanoma
- dendritic cells
- innate immunity
- tumor microenvironment
- cancer immunotherapy
- myeloid cells
Honors and awards
- Cancer Research Institute, Irvington Postdoctoral Fellowship
Publications
Selected publications
- Ruhland, M.K., Roberts, E.W., Cai, E., Mujal, A.M., Marchuk, K., Beppler, C., Nam, D., Serwas, N., Binnewies, M., Krummel, M.F., (2020). Visualizing synaptic transfer of tumor antigens among dendritic cells. Cancer Cell, 37(6):786-799.e5. doi: 10.1016/j.ccell.2020.05.002.
- Freedman, T.S., Headley, M.B., Serwas, N., Ruhland, M.K., Castellanos C.A., Combes, A.J., Krummel,. M.F., (2020). Lessons of COVID-19: A roadmap for post-pandemic science. J Exp Med, 217 (9): e20201276. doi:10.1084/jem.20201276
- Binnewies, M., Mujal, A.M., Pollack, J.L., Combes, A.J., Hardison, E.A., Barry, K.C.,Tsui, J.,Ruhland, M.K., Kersten, K., Abushawish, M.A., Spasic, M., Giurintano, J.P., Chan, V.,Daud, A.I., Ha, P., Ye, C.J., Roberts, E.W., Krummel, M.F. (2019).Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T cell Immunity. Cell. 177(3):556-571.e16. doi: 10.1016/j.cell.2019.02.005
- Ruhland M.K., Loza, A.J., Capietto, A.H., Luo, X., Knolhoff, B.L., Flanagan, K.C., Belt, B.A., Alspach, E., Leahy, K., Luo, J., Schaffer, A., Edwards, J.R., Longmore, G., Faccio, R., DeNardo, D.G., Stewart S.A., (2016). Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis. Nature Communications. 7(11762). doi:10.1038/ncomms11762
- Ruhland M.K., Coussens, L.M., Stewart, S.A. (2016). Senescence and cancer: An evolving inflammatory paradox. Biochim Biophys Acta. 1865(1):14-22. doi: 10.1016/j.bbcan.2015.10.001
- Luo, X., Fu, Y., Loza, A.J., Murali, B., Leahy, K., Ruhland, M.K., Gang, M., Su, X., Zamani, A., Shi, Y., Lavine, K., Ornitz, D.M., Weilbaecher, K.N., Long, F., Novack, D.V., Faccio, R., Longmore, G., Stewart, S.A. (2016). Stromal-initiated changes in the bone promote metastatic niche development. Cell Reports. 14(1):82-92. doi: 10.1016/j.celrep.2015.12.016
- Alspach, E., Flanagan K.C., Luo X., Ruhland M.K., Huang H., Pazolli E., Donlin M.J., Marsh T., Piwnica-Worms D., Monahan J., Novack D.V., McAllister S.S., Stewart S.A. (2014). p38MAPK plays a crucial role in stromal mediated tumorigenesis. Cancer Discovery. 4(6):716-29. doi: 10.1158/2159-8290.CD-13-0743
- Luo, X., Ruhland, M.K., Pazolli, E., Lind, A.C., Stewart, S.A. (2011). Osteopontin stimulatespreneoplastic cellular proliferation through activation of the MAPKpathway. Molecular Cancer Research. 9(8):1018-1029. doi: 10.1158/1541-7786.MCR-10-0472
Publications
Holistic Characterization of Tumor Monocyte-to-Macrophage Differentiation Integrates Distinct Immune Phenotypes in Kidney Cancer
Cancer Immunology ResearchVisualizing Synaptic Transfer of Tumor Antigens among Dendritic Cells
Cancer CellUnleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity
CellSenescence and cancer
Biochimica et Biophysica Acta - Reviews on CancerStromal-Initiated Changes in the Bone Promote Metastatic Niche Development
Cell ReportsStromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis
Nature communicationsP38MAPK plays a crucial role in stromal-mediated tumorigenesis
Cancer discoveryOsteopontin stimulates preneoplastic cellular proliferation through activation of the MAPK pathway
Molecular Cancer Research